Autopsy report · NCT00524173
Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B
Cause of deathNo reason given
Life of this trial
- Ran for about 9 years 6 months before it stopped.
- 35 participants enrolled.
- Results were posted on the registry 1 year 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Sponsor type
- US National Institutes of Health
- Conditions
- Hepatitis B
- Interventions
- Tenofovir & Emtricitabine; Tenofovir
- Participants
- 35
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.